Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum

Detalhes bibliográficos
Autor(a) principal: Moura L.*
Data de Publicação: 2012
Outros Autores: Dohms J., Almeida J.M.*, Ferreira P.S.*, Backes R.G.*, Biffi, Claudia Pies
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da Udesc
dARK ID: ark:/33523/00130000097jz
Texto Completo: https://repositorio.udesc.br/handle/UDESC/9107
Resumo: Adhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed into an oil emulsion creating a novel MG vaccine. Six different protein concentrations (50, 100, 200, 400, 800, and 1000μg/bird) were tested with two equal concentration doses at four and seven weeks of age. In addition, many control groups were needed such as bacterin, membrane, no vaccine or challenge, oil emulsion alone, and no vaccine but challenged. Three weeks following the second vaccination, 50% of the birds in each treatment group were challenged with MG strain S6. The remaining birds were left as contacts to verify protection against horizontal transmission. All birds were bled before vaccinations, challenge and euthanasia. Birds were negative for MG at the first vaccination, as shown by serum plate agglutination test. At necropsy, tissue samples (trachea, lungs, and air sacs) were collected for histopathological examination. Swabs from trachea were used for PCR analysis. ELISA results showed a strong immune response to both protein preparations and almost the same response level for different doses tested, proving the immunogenic features of MGC1 and MGC2. However, humoral responses failed to prevent MG infection and disease when challenged as demonstrated by PCR and histopathology. MGC1 contact birds showed some degree of infection by PCR analysis. In addition, histopathological and ELISA results suggest that contact birds did not have enough time to develop lesions and to mount an immune response.
id UDESC-2_26b5656f8136fc71e19860c6a8c91715
oai_identifier_str oai:repositorio.udesc.br:UDESC/9107
network_acronym_str UDESC-2
network_name_str Repositório Institucional da Udesc
repository_id_str 6391
spelling Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticumAdhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed into an oil emulsion creating a novel MG vaccine. Six different protein concentrations (50, 100, 200, 400, 800, and 1000μg/bird) were tested with two equal concentration doses at four and seven weeks of age. In addition, many control groups were needed such as bacterin, membrane, no vaccine or challenge, oil emulsion alone, and no vaccine but challenged. Three weeks following the second vaccination, 50% of the birds in each treatment group were challenged with MG strain S6. The remaining birds were left as contacts to verify protection against horizontal transmission. All birds were bled before vaccinations, challenge and euthanasia. Birds were negative for MG at the first vaccination, as shown by serum plate agglutination test. At necropsy, tissue samples (trachea, lungs, and air sacs) were collected for histopathological examination. Swabs from trachea were used for PCR analysis. ELISA results showed a strong immune response to both protein preparations and almost the same response level for different doses tested, proving the immunogenic features of MGC1 and MGC2. However, humoral responses failed to prevent MG infection and disease when challenged as demonstrated by PCR and histopathology. MGC1 contact birds showed some degree of infection by PCR analysis. In addition, histopathological and ELISA results suggest that contact birds did not have enough time to develop lesions and to mount an immune response.2024-12-06T19:05:06Z2012info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlep. 1569 - 15761678-416210.1590/S0102-09352012000600024https://repositorio.udesc.br/handle/UDESC/9107ark:/33523/00130000097jzArquivo Brasileiro de Medicina Veterinaria e Zootecnia646Moura L.*Dohms J.Almeida J.M.*Ferreira P.S.*Backes R.G.*Biffi, Claudia Piesengreponame:Repositório Institucional da Udescinstname:Universidade do Estado de Santa Catarina (UDESC)instacron:UDESCinfo:eu-repo/semantics/openAccess2024-12-07T21:00:47Zoai:repositorio.udesc.br:UDESC/9107Biblioteca Digital de Teses e Dissertaçõeshttps://pergamumweb.udesc.br/biblioteca/index.phpPRIhttps://repositorio-api.udesc.br/server/oai/requestri@udesc.bropendoar:63912024-12-07T21:00:47Repositório Institucional da Udesc - Universidade do Estado de Santa Catarina (UDESC)false
dc.title.none.fl_str_mv Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
spellingShingle Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
Moura L.*
title_short Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_full Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_fullStr Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_full_unstemmed Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_sort Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
author Moura L.*
author_facet Moura L.*
Dohms J.
Almeida J.M.*
Ferreira P.S.*
Backes R.G.*
Biffi, Claudia Pies
author_role author
author2 Dohms J.
Almeida J.M.*
Ferreira P.S.*
Backes R.G.*
Biffi, Claudia Pies
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Moura L.*
Dohms J.
Almeida J.M.*
Ferreira P.S.*
Backes R.G.*
Biffi, Claudia Pies
description Adhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed into an oil emulsion creating a novel MG vaccine. Six different protein concentrations (50, 100, 200, 400, 800, and 1000μg/bird) were tested with two equal concentration doses at four and seven weeks of age. In addition, many control groups were needed such as bacterin, membrane, no vaccine or challenge, oil emulsion alone, and no vaccine but challenged. Three weeks following the second vaccination, 50% of the birds in each treatment group were challenged with MG strain S6. The remaining birds were left as contacts to verify protection against horizontal transmission. All birds were bled before vaccinations, challenge and euthanasia. Birds were negative for MG at the first vaccination, as shown by serum plate agglutination test. At necropsy, tissue samples (trachea, lungs, and air sacs) were collected for histopathological examination. Swabs from trachea were used for PCR analysis. ELISA results showed a strong immune response to both protein preparations and almost the same response level for different doses tested, proving the immunogenic features of MGC1 and MGC2. However, humoral responses failed to prevent MG infection and disease when challenged as demonstrated by PCR and histopathology. MGC1 contact birds showed some degree of infection by PCR analysis. In addition, histopathological and ELISA results suggest that contact birds did not have enough time to develop lesions and to mount an immune response.
publishDate 2012
dc.date.none.fl_str_mv 2012
2024-12-06T19:05:06Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv 1678-4162
10.1590/S0102-09352012000600024
https://repositorio.udesc.br/handle/UDESC/9107
dc.identifier.dark.fl_str_mv ark:/33523/00130000097jz
identifier_str_mv 1678-4162
10.1590/S0102-09352012000600024
ark:/33523/00130000097jz
url https://repositorio.udesc.br/handle/UDESC/9107
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Arquivo Brasileiro de Medicina Veterinaria e Zootecnia
64
6
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv p. 1569 - 1576
dc.source.none.fl_str_mv reponame:Repositório Institucional da Udesc
instname:Universidade do Estado de Santa Catarina (UDESC)
instacron:UDESC
instname_str Universidade do Estado de Santa Catarina (UDESC)
instacron_str UDESC
institution UDESC
reponame_str Repositório Institucional da Udesc
collection Repositório Institucional da Udesc
repository.name.fl_str_mv Repositório Institucional da Udesc - Universidade do Estado de Santa Catarina (UDESC)
repository.mail.fl_str_mv ri@udesc.br
_version_ 1842258105891553280